| Literature DB >> 30712876 |
Chengcheng Jin1, Georgia K Lagoudas2, Chen Zhao3, Susan Bullman4, Arjun Bhutkar1, Bo Hu5, Samuel Ameh1, Demi Sandel1, Xu Sue Liang1, Sarah Mazzilli6, Mark T Whary7, Matthew Meyerson4, Ronald Germain3, Paul C Blainey8, James G Fox9, Tyler Jacks10.
Abstract
Lung cancer is closely associated with chronic inflammation, but the causes of inflammation and the specific immune mediators have not been fully elucidated. The lung is a mucosal tissue colonized by a diverse bacterial community, and pulmonary infections commonly present in lung cancer patients are linked to clinical outcomes. Here, we provide evidence that local microbiota provoke inflammation associated with lung adenocarcinoma by activating lung-resident γδ T cells. Germ-free or antibiotic-treated mice were significantly protected from lung cancer development induced by Kras mutation and p53 loss. Mechanistically, commensal bacteria stimulated Myd88-dependent IL-1β and IL-23 production from myeloid cells, inducing proliferation and activation of Vγ6+Vδ1+ γδ T cells that produced IL-17 and other effector molecules to promote inflammation and tumor cell proliferation. Our findings clearly link local microbiota-immune crosstalk to lung tumor development and thereby define key cellular and molecular mediators that may serve as effective targets in lung cancer intervention.Entities:
Keywords: IL-17; inflammation; lung adenocarcinoma; lung cancer; microbiota; neutrophils; tumor microenvironment; γδ T cells
Mesh:
Substances:
Year: 2019 PMID: 30712876 PMCID: PMC6691977 DOI: 10.1016/j.cell.2018.12.040
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582